Blog
Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026
NeuroPace, Inc. NPCE enters 2026 after posting $100 million in 2025 revenue, up 25% year over year. The business is also moving toward a cleaner mix, with the core RNS System taking center stage as
NPCE RNS System Explained: Growth Drivers and Setup for 2026
NeuroPace, Inc. NPCE is building a procedure-driven growth story around its RNS System, a brain-responsive implant designed to reduce seizures in adults with drug-resistant focal epilepsy. The
GSK Out-Licenses Rights for Rare Liver Disease Drug to Alfasigma
GSK plc GSK signed a license agreement with Italy-based Alfasigma. Per the terms of the agreement, Alfasigma has acquired exclusive global rights from GSK to develop and market linerixibat, an
Should Investors Hold or Fold Figma Stock at a P/S Multiple of 9.46X?
Figma FIG stock is trading at a premium, with a forward 12-month Price/Sales of 9.46X compared with the Zacks Internet - Software industry’s 4.03X. The overvaluation is further established by the
JNJ Gets EU Nod for Expanded Use of Akeega in Prostate Cancer
J&J JNJ announced that the European Commission has approved its precision therapy, Akeega (niraparib and abiraterone acetate dual action tablet), for expanded use in prostate cancer. The regulatory
HPE Q1 Earnings Surpass Expectations, Revenues Rise Y/Y
Hewlett Packard Enterprise HPE reported better-than-expected results for first-quarter fiscal 2026. The company’s non-GAAP earnings of 65 cents per share beat the Zacks Consensus Estimate by 10.2%
XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study
Shares of Xenon Pharmaceuticals XENE surged 49.6% yesterday after the company announced positive top-line data from the phase III X-TOLE2 study, which evaluated its lead pipeline candidate
Recurring Contracts & Solid Liquidity Aid Booz Allen Amid Rising Costs
Booz Allen Hamilton’s BAH top line is gaining from long-term government contracts, providing steady revenues and offsetting market volatility. The company’s strong strategies improve operational
NeuroPace's Seizure ID and New Indication Could Expand RNS Demand
NeuroPace, Inc. NPCE is moving beyond a device-only story and leaning into software and workflow tools that aim to expand clinician capacity. The company is also pursuing an indication expansion
VAALCO Pivots Drilling Plan After Encountering Water-Bearing Reservoir
VAALCO Energy EGY, an independent exploration and production company, has recently finished drilling the ET-14P exploration well at the Etame field, which was part of its Phase Three drilling
Why Should You Consider Retaining Advance Auto in Your Portfolio Now?
Advance Auto Parts, Inc. AAP, is a leading automotive parts provider in North America, serving both the do-it-yourself or DIY and professional installers.
While AAP expects some hiccups due to
3D Systems Posts Narrower Loss in Q4 Earnings, Revenues Rise Y/Y
3D Systems DDD reported a fourth-quarter 2025 non-GAAP loss of 13 cents per share, narrower than the reported loss of 19 cents per share in the year-ago quarter. The Zacks Consensus Estimate was
De-Clogging the Future: Why Photonics is AI's Ultimate Growth Engine
Understanding “Picks and Shovels” Investments
During the California Gold Rush of the mid-1800s, the term “picks and shovels” became prominent. In the case of the Gold Rush, picks-and-shovel plays
EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y
Editas Medicine EDIT reported a loss of 6 cents per share in the fourth quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 27 cents. The company had incurred a loss of 55 cents
Kronos' Q4 Earnings Miss Estimates, Sales Beat Amid Economic Weakness
Kronos Worldwide, Inc. KRO reported a fourth-quarter 2025 net loss of $82.8 million or 72 cents per share. This compares unfavorably to a loss of $13.2 million, or 12 cents per share, in the
Small-Business Optimism Index Declined in February
With assurances that the war in Iran will be a short-lived “excursion,” oil prices yesterday pulled back from their highest levels in almost 20 years — the first drop in oil prices since the U.S
BASFY Divests Hydrosulfite Assets as Portfolio Review Continues
BASF SE BASFY has signed a definitive agreement to divest hydrosulfite-related assets to Silox. The transaction includes intellectual property rights, special containers, selected production
AMD Surges 109% in a Year: Is There More Room for the Stock to Grow?
Advanced Micro Devices AMD shares have surged 109% in the trailing 12-month period, outperforming the broader Zacks Computer and Technology sector’s 34.1% return. Strong demand for data center EPYC
How Strong Are Ford Pro's Fundamentals Amid 2026 Pressures?
Ford Motor Company’s F Ford Pro segment continued to demonstrate its role as a major profit driver for the company, generating more than $66 billion in revenues and $6.8 billion in EBIT with a
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
CONMED Corporation CNMD is well-positioned for growth on the back of rising adoption of its high-margin, differentiated platforms like AirSeal, Buffalo Filter and BioBrace. The company’s long-term
Should You Bet on CLS Stock Amid Rising Estimate Revision Trend?
Earnings estimates for Celestica Inc. CLS for 2026 and 2027 have moved up 7.5% and 7.1% to $8.83 and $12.61 per share, respectively, over the past 60 days. The positive estimate revision depicts
HUBS Rides on Solid Subscriber Revenue Growth: Will it Sustain?
HubSpot, Inc. HUBS is witnessing solid user engagement in its customer relationship management platform, which is driving subscription-based revenues. In the fourth quarter, Subscription revenues
ZION's Revenues Rise in 2025: What Will Drive Growth Ahead?
Zions Bancorporation ZION delivered solid revenue growth in 2025, highlighting higher net interest income (NII) and fee income. The company’s net revenues (tax equivalent) of $3.43 billion were up
Here's Why Investors Should Give Ryder System Stock a Miss Now
Ryder System R is grappling with challenges, which are significantly impacting its financial stability. The increased operating expenses and weak liquidity are major headwinds hurting the company’s



